Gas chromatography/mass spectrometry screening of serum metabolomic biomarkers in hepatitis B virus infected cirrhosis patients

Clinical Chemistry and Laboratory Medicine

Volumn 47, Issue 3, 2009, Pages 305-310

  Xue, Ruyi ^a   Dong, Ling ^a   Wu, Hao ^a   Liu, Taotao ^a   Wang, Jiyao ^a   Shen, Xizhong ^a,b  

^a FUDAN UNIVERSITY   (China)

^b ZHONGSHAN HOSPITAL OF FUDAN UNIVERSITY   (China)

Author keywords

Biomarker; Cirrhosis; Gas chromatography mass spectrometry; Hepatitis B virus (HBV); Metabolomic

Indexed keywords

1 NAPHTHALENAMINE; ACETIC ACID; BIOLOGICAL MARKER; BUTYRIC ACID; GLUCOSE; HEXANOIC ACID; LACTIC ACID; PHOSPHORIC ACID; SORBITOL; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; LIVER CIRRHOSIS; LIVER FUNCTION TEST; MALE; MASS FRAGMENTOGRAPHY; METABOLOMICS; PRIORITY JOURNAL; SCREENING TEST;

ADULT; BIOLOGICAL MARKERS; DIAGNOSIS, DIFFERENTIAL; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HEPATITIS B; HEPATITIS B VIRUS; HUMANS; LIVER CIRRHOSIS; LIVER FUNCTION TESTS; MALE; METABOLOMICS; MIDDLE AGED; SENSITIVITY AND SPECIFICITY;

HEPATITIS B VIRUS;

EID: 63849185899     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/CCLM.2009.083     Document Type: Article

References (25)

1. World Health Organization. Hepatitis B: fact sheet no. 204. Geneva, Switzerland: World Health Organization, 2000.
2. Perz JF, Armstrong GL, Farrington LA, Hutin YJ, Bell BP. The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide. J Hepatol 2006;45:529-38.
3. Goodacre R. Metabolomics of a superorganism. J Nutr 2007;137:259S-66S.
4. Tang HR, Wang YL. Metabonomics: a revolution in progress. Prog Biochem Biophys 2006;33:401-7.
5. Xue RY, Lin ZX, Deng CH, Dong L, Liu TT, Wang JY, et al. A serum metabolomic investigation on hepatocellular carcinoma patients by chemical derivatization followed by gas chromatography/mass spectrometry. Rapid Commun Mass Spectrom 2008;22:3061-8.
6. Claudino WM, Quattrone A, Biganzoli L, Pestrin M, Bertini I, Leo AD. Metabolomics: available results, current research projects in breast cancer, and future applications. J Clin Oncol 2007;25:2840-6.
7. Wikoff WR, Gangoiti JA, Barshop BA, Siuzdak, G. Metabolomics identifies perturbations in human disorders of propionate metabolism. Clin Chem 2007;53:2169-76.
8. Bogdanov M, Matson WR, Wang L, Matson T, Saunders- Pullman R, Bressman SS, et al. Metabolomic profiling to develop blood biomarkers for Parkinson's disease. Brain 2008;131:389-96.
9. Dunn WB, Ellis DI. Metabolomics: current analytical platforms and methodologies. Trends Anal Chem 2005;24: 285-94.
10. Van der Greef J, Davidov E, Verheij ER, Vogels J, van der Heijden R, Adourian AS, et al. The role of metabolomics in systems biology. In: Harrigan GG, Goodacre R, editors. Metabolic profiling: its role in biomarker discovery and gene function analysis. London, UK: Kluwer Academic Publishers, 2003:170-98.
11. Jiye A, Trygg J, Gullberg J, Johansson AI, Jonsson P, Antti H, et al. Extraction and GC/MS analysis of the human blood plasma metabolome. Anal Chem 2005; 77:8086-94.
12. Yu K, Sheng GP, Sheng JF, Chen YM, Xu W, Liu XL, et al. A metabonomic investigation on the biochemical perturbation in liver failure patients caused by hepatitis B virus. J Proteome Res 2007;6:2413-9.
13. O'Hagan S, Dunn WB, Knowles JD, Broadhurst D, Williams R, Ashworth JJ, et al. Closed-loop, multi-objective optimization of two-dimensional gas chromatography/ mass spectrometry for serum metabolomics. Anal Chem 2007;79:464-76.
14. Society of Infectious Disease and Society of Liver Disease, Chinese Medical Association. Chronic hepatitis B prevention and treatment guidelines. Chin J New Drugs Clin Rem 2006;25:146-60.
15. Pan BS, Zhang WZ, Chen MS, Guo W, Zhou HW, Ni XZ. A study for harmonization and reference range of serum ALT measurement in Shanghai. Lab Med 2005;20: 417-20.
16. Child CG, Turcotte JG. Surgery and portal hypertension. In: Child CG, editor. The liver and portal hypertension. Philadelphia, PA: WB Saunders Co., 1964:50-64.
17. Pugh RN, Murray-Lyon IM, Dawson JL, Pietroni MC,Williams R. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 1973;60:646-9.
18. Mallios RR. Predicting class II MHC/peptide multi-level binding with an iterative stepwise discriminant analysis meta-algorithm. Bioinformatics 2001;17:942-8.
19. Feng B, Wu SM, Lv S, Liu F, Chen HS, Yan XZ, et al. Metabolic profiling analysis of a D-galactosamine/lipopolysaccharide- induced mouse model of fulminant hepatic failure. J Proteome Res 2007;6:2161-7.
20. Halket JM, Waterman D, Przyborowska AM, Patel R, Fraser PD, Bramley PM. Chemical derivatization and mass spectral libraries in metabolic profiling by GC/MS and LC/MS/MS. J Exp Bot 2005;56:219-43.
21. Smith TE, Tomlinson AJ, Mlotkiewicz JA, Abbott DH. Female marmoset monkeys (Callithrix jacchus) can be identified from the chemical composition of their scent marks. Chem Senses 2001;26:449-58.
22. Jaynes DB, Kaspar TC, Colvin TS, James DE. Cluster analysis of spatiotemporal corn yield patterns in an Iowa field. Agron J 2003;95:574-86.
23. Pilger E, Pristautz H, Pfeiffer KP, Kostner G. Risk factors for peripheral atherosclerosis. Retrospective evaluation by stepwise discriminant analysis. Arterioscler Thromb Vasc Biol 1983;3:57-63.
24. Turner JM, Hall RA, Whittaker M, Holder RL, Kricka LJ. Application of stepwise discriminant analysis in the phenotyping of plasma cholinesterase variants. Ann Clin Biochem 1985;22:175-8.
25. Iskandrian AS, Heo J, Lemlek J, Ogilby JD. Identification of high-risk patients with left main and three-vessel coronary artery disease using stepwise discriminant analysis of clinical, exercise, and tomographic thallium data. Am Heart J 1993;125:221-5.